Is it a good time to buy this top retail giant? The post The pros and cons of buying Wesfarmers shares this month appeared ...

Wesfarmers delivered solid growth across its portfolio, driven by operational efficiencies and market-leading retail offerings. Key opportunities include the health sector, retail media ...

Retailing of home improvement and outdoor living products and supply of building materials, retailing of general merchandise and apparel products, retailing of office and technology products ...

Australia's Wesfarmers sees tariff inflation risk as profit beats forecast Australia's biggest non-food retailer Wesfarmers said it may raise prices as a soft local dollar drives up supply costs ...

The Wesfarmers-owned hardware giant has already expanded into pet care and cleaning. Now it sees a $1.5 billion opportunity ...

In a report released on March 27, Lisa Deng from Goldman Sachs maintained a Buy rating on Wesfarmers Limited (WFAFF – Research Report), with a price target of A$80.40. The company’s shares ...

Australian Pharmaceutical Industries (API), a wholly-owned subsidiary of Wesfarmers Health, has unveiled a new online B2B ...

Wesfarmers chairman Michael Chaney has attacked Donald Trump’s tariffs bombshell over concern it will inflict major damage to ...

Researchers from the Wesfarmers Center of Vaccines and Infectious Diseases, based at The Kids Research Institute Australia, ...

Australian Pharmaceutical Industries (API), a wholly-owned subsidiary of Wesfarmers Health, has unveiled a new online B2B e-Hub, myAPI, to support their more than 4,000 wholesale pharmacy customers.

Australian Pharmaceutical Industries (API) has launched an online B2B hub – MyAPI – for its wholesale pharmacy customers.

What is the current share price of Wesfarmers Limited (WES)? Wesfarmers Limited's (WES) current share price is $69.00. This constitutes a price movement of 5.34% when compared to the share price 7 ...